Book an assessment
A person lifting a loaded barbell in a gym

Strength: what your hand says about the rest of your body

A hand dynamometer costs very little and takes ten seconds. And what it measures predicts better than muscle mass, which is what almost everyone tries to measure instead.

September 4, 2026 8 min de lectura PROFIT7 medical team

Illustrative image

There is a clinical test that consists of squeezing a device with your hand as hard as you can. It is called grip dynamometry, it takes a few seconds and requires no preparation. Its ability to predict mortality is one of the most consistently reproduced things in the aging literature.

The strange part is not that it works. The strange part is why it works, and what that implies.

Mass and strength are not the same — and they are not worth the same

Gym intuition says muscle is measured in kilos: how much muscle mass you have. And yes, both reduced muscle mass and reduced strength are associated with a higher risk of all-cause mortality in older adults.

But when the two are compared, they do not tie. Low strength is more closely associated with poor health status and mortality than low mass, especially in older people with chronic conditions.

It is not how much muscle you carry. It is how much of that muscle you can use.

It makes sense if you think about what strength is: it is not only tissue, it is tissue plus the nervous system's capacity to recruit it. It is a measure of function, not of inventory. And function is what determines whether you can get up from a chair, carry a suitcase or recover from a fall.

The magnitude, in numbers

Sarcopenia — the age-associated loss of muscle mass and strength — has been studied with prospective follow-up. In one with six years of follow-up, mortality rates were 2.1 per 100 person-years in those without sarcopenia and 4.8 per 100 person-years in those with it.

And the association has been reproduced at scale: a prospective cohort study of the oldest old, with data from 28 countries, found a graded association between muscle strength and all-cause mortality. Graded means it is not a threshold: more strength, less risk, across the whole range.

In ten-year cohorts of the general adult population, grip strength and muscle weakness were associated with a higher risk of total and premature mortality in middle-aged people too — not only in the oldest.

The part that changes what you do tomorrow

Here is the important bit, and it is a sentence from the literature itself: muscle strength is highly adaptable to resistance training at any age.

At any age. There is no window that closes. And the dose that appears in the research is surprisingly modest: moderate-intensity resistance training twice a week is described as a promising strategy for improving grip strength in older adults with sarcopenia.

Two sessions. Not six days, not two hours a day, not an athlete's program. It is one of the most favorable effort-to-benefit ratios in the whole of longevity, and it is also one of the least sold — because it is hard to charge much for something that simple.

What to measure, then

  • Grip strength with a dynamometer: fast, cheap, reproducible, and with the best track record as a predictor.
  • Strength in large patterns — push, pull, hip hinge, squat — because that is what translates into daily life.
  • Body composition as context, not as the goal: it informs, but it predicts less than strength.
  • And a repeat of the measurement at three or six months: the trajectory is worth more than the point.

The joint conclusion with the other article in this area is fairly clear: the two markers with the best evidence in all of longevity — how much oxygen you can use and how much force you can produce — are both trainable, and neither of them is bought in a bottle. That does not make the rest of what we do irrelevant. It puts it in its place: on top of a base that has to be built first.

Where the evidence stands

What the evidence supports

  • That both reduced muscle mass and reduced strength are associated with a higher risk of all-cause mortality in older adults.
  • That low strength is more closely associated with poor health status and mortality than low mass, especially in the presence of chronic conditions.
  • That in a 6-year prospective follow-up mortality was 2.1 per 100 person-years without sarcopenia against 4.8 with sarcopenia, and that a study across 28 countries found a graded association between strength and mortality.
  • That muscle strength is highly adaptable to resistance training at any age, and that two moderate-intensity sessions a week are described as a promising strategy in older adults with sarcopenia.

What it does not yet

  • The evidence is mostly observational for the predictive part: association, not demonstrated causality.
  • Grip strength is a good population-level predictor, but a poor substitute for whole-body strength in one specific person.
  • There is no single training protocol established as optimal; the doses described are effective minimums, not ceilings.
  • Improving strength does not guarantee a change in outcome for an individual: that is what the population evidence suggests, not a personal promise.

Sources

  1. Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults Direct comparison between mass and strength as predictors.
  2. Association of Muscle Strength With All-Cause Mortality in the Oldest Old: Prospective Cohort Study From 28 Countries The graded association, across 28 countries.
  3. Handgrip Strength to Predict the Risk of All-Cause and Premature Mortality in Korean Adults: A 10-Year Cohort Study Ten-year cohort in middle-aged and older adults.
  4. Optimal dose of resistance training to improve handgrip strength in older adults with sarcopenia: a systematic review and network meta-analysis On the dose of resistance training.

This article is general information. It does not replace a medical assessment, and none of its statements should be read as an indication for treatment.

Your data, not an average.

Everything explained here only means something when it is applied to one specific person. That is the starting point.

See the Precision Assessment